Validity and Reliability of the 6-Minute Pegboard and Ring Test in Interstitial Lung Disease

NCT07122141 | Active Not Recruiting

• 1 other identifier: Upperextremity_ILD
• Study Type: observational
• Target: 27
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to investigate the validity and reliability of the 6 Minutes Pegboard and Ring Test (6PBRT) in patients with Interstitial Lung Disease (ILD).

Conditions

Interstitial Lung Diseases (ILD)

Keywords

6-minute pegboard and ring test; upper extremity; validity; reliability; Interstitial lung diseases (ILD)

Outcome Measures

Primary Outcomes (3)

• 6 Minutes Pegboard and Ring Test (6PBRT)

  The 6-Minute Pegboard and Ring Test (6PBRT) is designed to assess upper extremity functional capacity using unsupported arm movements. The setup includes four horizontally aligned bars: two at shoulder height and two positioned 20 cm above. Participants, seated with back support, sequentially transfer rings between the bars for six minutes, and the total number of rings moved serves as the performance score.

  Day 1

• 6 Minutes Walking Tests (6MWT)

  Total distance walked (in meters) during the 6MWT will be recorded. Higher distance reflects improved functional capacity.

  Day 1

• Unsupported Upper-Limb Exercise Test (UULEX)

  Patients will be instructed to lift five bars consecutively and rhythmically until the onset of fatigue. The bars will have incremental weights of 200 g, 500 g, 1 kg, and 2 kg, respectively. The duration of the activity will be recorded to assess the patients' endurance levels.

  Day 1

Secondary Outcomes (11)

• 1 Minute Sit to Stand Test (1MSTST)

  Day 1

• Spirometric measurements (Forced vital capacity - FVC)

  Day 1

• Spirometric measurements (First second forced expiratory volume - FEV1)

  Day 1

• Spirometric measurements (FEV1/FVC ratio)

  Day 1

• Carbon monoxide diffusion capacity

  Day 1

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Chest Diseases Clinic of Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital

You may qualify if:

• who were diagnosed with ILD according to the ATS/ERS/JRS/ALAT guidelines,
• were over 18 years of age,
• had not changed their treatment for the last 3 months,
• had a stable clinical status for the last 3 months.

You may not qualify if:

• Neurological comorbidity,
• Orthopedic comorbidity that impairs upper extremity function,
• Kyphoscoliosis and/or severe postural abnormalities,
• Uncontrolled cardiac problems,
• Uncontrolled diagnosis of Diabetes Mellitus,
• Ischemic heart disease,
• Newly diagnosed history of cancer,
• Diagnosis of obstructive pulmonary disease,
• Cognitive impairments such as Alzheimer's or dementia,
• Use of immunosuppressive medications (excluding corticosteroids),
• History of recent surgery,
• Refusal to answer questions,
• Refusal to participate voluntarily.

Sponsors & Collaborators

• Marmara University: lead

Study Sites (1)

Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases

Study Officials

• Anıl Gökçen, Phsiotheraphist

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physiotherapist

Study Record Dates

• First Submitted: August 7, 2025
• First Posted: August 14, 2025
• Study Start: April 25, 2025
• Primary Completion: September 1, 2025
• Study Completion: December 1, 2025
• Last Updated: August 14, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)